Menu Search
Equities

CARETEQ Ltd

CTQ:ASX

CARETEQ Ltd

Actions
Health CareHealth Care Providers
  • Price (AUD)0.014
  • Today's Change0.001 / 7.69%
  • Shares traded60.52k
  • 1 Year change-68.55%
  • Beta--
Data delayed at least 20 minutes, as of May 17 2024 05:49 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Careteq Limited is an Australia-based health-tech company, which has developed and commercialized an Assistive Living Technology platform. The Company is using its early-mover advantage in the Assistive Living Technology sector to revolutionize aged and disability care across the globe. Its brands include Sofihub, TEQ-FallsAlert and Embedded Health Solutions (EHS). The Sofihub brand is an advanced adaptive care technology that gives people of all ages and abilities the freedom to live independently, while reducing their reliance on family or professional careers. Sofihub has developed a suite of intelligent adaptive technology that enables the aged and at-risk members of society to live independently. TEQ-FallsAlert powered by Sofihub employs radar technology that provides continuous non-invasive monitoring, allowing care resources to be managed efficiently. EHS helps health care workers with professional knowledge and advice to help prevent incidents of medicine-related harm.

  • Revenue in AUD (TTM)7.28m
  • Net income in AUD-3.04m
  • Incorporated2016
  • Employees--
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		CTQ:ASX since
announced		Transaction
value
New Medical Enterprises Pty LtdDeal completed07 Dec 202307 Dec 2023Deal completed-30.00%321.00k
Data delayed at least 20 minutes, as of May 17 2024 05:49 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.